iifl-logo

Fortis Healthcare Ltd Shareholding Pattern

696.4
(4.38%)
Apr 30, 2025|12:09:58 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Fortis Healthcare Ltd SHAREHOLDING

Mar-2025Dec-2024Sep-2024Jun-2024Mar-2024

Promoter

-

-

-

-

-

Foreign

31.16%

31.16%

31.16%

31.16%

31.16%

Indian

0%

0%

0%

0%

0%

Total Promoter

-

-

-

-

-

Institutions

56.86%

56.82%

55.99%

55.62%

54.38%

Non-Institutions

11.96%

12.01%

12.83%

13.21%

14.44%

Total Non-Promoter

68.83%

68.83%

68.83%

68.83%

68.83%

Custodian

0%

0%

0%

0%

0%

Total

100%

100%

100%

100%

100%

  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 31.16%

Foreign: 31.16%

Indian: 0.00%

Non-Promoter- 56.86%

Institutions: 56.86%

Non-Institutions: 11.96%

Custodian: 0.00%

Fortis Health.: Related NEWS

Fortis Healthcare’s Subsidiary IHL Faces ₹76.19 Crore Tax Demand
4 Apr 2025|12:05 PM

The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.

Read More
Top Stocks for Today - 4th April 2025
4 Apr 2025|07:43 AM

Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.

Read More
Fortis Healthcare Q3 Profit Soars 89.5% YoY, Revenue Up 14.8%
9 Feb 2025|10:53 PM

EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.

Read More
Fortis Healthcare Boosts Stake in Agilus Diagnostics with ₹429 Crore IFC Deal
23 Dec 2024|11:59 AM

The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.

Read More
Fortis Healthcare Reports 1.6% Profit Growth, 12.3% Revenue Increase in Q2
12 Nov 2024|12:03 PM

Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.

Read More
Fortis Buys Out PE Investors in Diagnostics Arm
9 Aug 2024|08:32 AM

Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.